⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
SpliceBio nombra a Don Muñoz director financiero
businesswire.com
NVO
Dewpoint Therapeutics Launches Initiative to Build Viral Condensate Phenomics Atlas for HPV
globenewswire.com
NVO
Novo Nordisk unveils the inaugural State of Weight and Health Report™, offering new insights that shed light on America's obesity epidemic
prnewswire.com
NVO
IPOS
$18.67 Bn MASH Treatment Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029 & 2034
globenewswire.com
MDGL
NVO
LLY
AZN
G-Protein Coupled Receptors (GPCRs) Market Size to Hit USD 6.04 Billion by 2032, Growing at a CAGR of 5.59% - SNS Insider
globenewswire.com
NVO
Novo Nordisk Launches Wegovy™ Pill, Expanding Patient Choice and Access With knownwell as a Recognized NovoCare® Provider
businesswire.com
NVO
RO LAUNCHES WEGOVY® PILL THROUGH INTEGRATION WITH NOVO NORDISK
prnewswire.com
NVO
Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
prnewswire.com
NVO
TrimRx Compounded Semaglutide Guide: FDA Safety Framework, Pricing Analysis, and Telehealth Process Explained for Weight Management Patients
accessnewswire.com
NVO
LLY
Elevate Health GLP-1 Weight Loss Consumer Guide Examines Telehealth Program Structure, Compounding Safety Context, and Pricing for 2026
accessnewswire.com
NVO
LLY